Agilon Health AGL
$90.24 +$0.74 (+0.83%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $90.22 -0.02%
Open$89.62
Prev close$89.50
Day range$85.77 – $90.41
Volume266.3K
Market cap$1.52B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$1.52B+5.9% YoY
Operating profit$24.11M+118.4% YoY
Net profit$34.91M+131.7% YoY
Diluted EPS$1.97+129.6% YoY
Free cash flow$46.62M+234.4% YoY
Operating cash flow$49.87M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin3.0%
Operating margin-2.0%
Net margin-1.5%
Return on equity-29.7%
Return on assets-5.5%
Return on invested capital-25.2%
Current ratio1.13
Liabilities / assets82.1%
Cash & investments$239.76M
Total debt$33.43M
Net cash (debt)$206.34M
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.52B | $1.49B | $1.42B | $5.93B | $1.57B |
| Total Operating Revenue | $1.52B | $1.49B | $1.42B | $5.93B | $1.57B |
| Cost of Revenue | $1.42B | $1.39B | $1.36B | $6.09B | $1.66B |
| Gross Profit | $97.98M | $107.14M | $65.02M | -$160.02M | -$90.67M |
| Operating Expense | $73.87M | $95.37M | $61.02M | $267.13M | $67.07M |
| Selling and Admin Expenses | $67.13M | $88.51M | $54.23M | $238.54M | $60.10M |
| -General & Admin Expense | $67.13M | $88.51M | $54.23M | $238.54M | $60.10M |
| Depreciation & Amortization & Depletion | $6.74M | $6.86M | $6.79M | $28.59M | $6.97M |
| -Depreciation & Amortization | $6.74M | $6.86M | $6.79M | $28.59M | $6.97M |
| Operating Profit | $24.11M | $11.77M | $4.00M | -$427.15M | -$157.74M |
| Net Non-Operating Interest Income (Expense) | -$1.74M | -$1.61M | -$1.81M | -$6.64M | -$1.72M |
| Non-Operating Interest Expense | $1.74M | $1.61M | $1.81M | $6.64M | $1.72M |
| Other Income (Expense) | $16.55M | $7.42M | $27.76M | $29.70M | -$28.10M |
| Earnings from Equity Interest | -$979,000.00 | -$7.60M | $11.73M | -$1.84M | -$33.05M |
| Other Non-Operating Income (Expenses) | $17.52M | $15.02M | $16.03M | $67.62M | $41.04M |
| Pretax Profit | $38.91M | $17.58M | $29.94M | -$404.10M | -$187.56M |
| Tax | $4.00M | -$375,000.00 | $28,000.00 | $1.25M | $1.32M |
| Net Profit | $34.91M | $17.96M | $48.92M | -$391.35M | -$188.88M |
| Profit from Continuing Operations | $34.91M | $17.96M | $29.92M | -$405.35M | -$188.88M |
| Net Income from Discontinuous Operations | $0.00 | $0.00 | $19.00M | $14.00M | $0.00 |
| Net Income to Parent Company | $34.91M | $17.96M | $48.92M | -$391.35M | -$188.88M |
| Net Income to Common Stockholders | $34.91M | $17.96M | $48.92M | -$391.35M | -$188.88M |
| Basic EPS | $2.08 | $1.07 | $2.95 | -$23.75 | -$11.50 |
| Diluted EPS | $1.97 | $1.04 | $2.94 | -$23.75 | -$11.50 |
| Special Income (Charges) | – | – | – | -$36.09M | – |
| -Less:Write Off | – | – | – | $36.09M | – |
| Minority Interests | – | – | – | $0.00 | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.57B | $1.59B | $1.50B | $1.27B | $1.27B |
| Total Current Assets | $1.40B | $1.42B | $1.32B | $1.10B | $1.10B |
| Cash and Cash Equivalents & Short-Term Investments | $239.76M | $185.63M | $231.41M | $285.14M | $285.14M |
| -Cash and Cash Equivalents | $174.40M | $107.18M | $139.99M | $173.71M | $173.71M |
| -Short Term Investments | $65.36M | $78.44M | $91.42M | $111.43M | $111.43M |
| Receivables | $1.02B | $1.06B | $899.75M | $673.79M | $673.79M |
| -Accounts Receivable | $1.02B | $1.06B | $899.75M | $673.79M | $673.79M |
| Restricted Cash | $71.98M | $71.63M | $71.58M | $0.00 | $0.00 |
| Other Current Assets | $70.93M | $101.49M | $118.44M | $137.76M | $137.76M |
| Total Non-Current Assets | $165.73M | $172.80M | $183.77M | $174.59M | $174.59M |
| Net PPE | $28.48M | $29.39M | $30.13M | $28.96M | $28.96M |
| -Gross PPE | $28.48M | $29.39M | $30.13M | $64.50M | $64.50M |
| Investments and Advances | $63.97M | $65.08M | $72.15M | $59.79M | $59.79M |
| -Long Term Equity Investment | $63.97M | $65.08M | $72.15M | $59.79M | $59.79M |
| Non-Current Note Receivables | $11.07M | $12.60M | $13.43M | $14.16M | $14.16M |
| Non-Current Prepaid Assets | $2.08M | $2.08M | $2.08M | $2.08M | $2.08M |
| Goodwill and Other Intangible Assets | $56.85M | $60.13M | $62.45M | $65.73M | $65.73M |
| -Other Intangible Assets | $56.85M | $60.13M | $62.45M | $65.73M | $65.73M |
| Other Non-Current Assets | $3.28M | $3.52M | $3.54M | $3.89M | $3.89M |
| Total Liabilities | $1.28B | $1.36B | $1.32B | $1.14B | $1.14B |
| Total Current Liabilities | $1.23B | $1.31B | $1.27B | $1.08B | $1.08B |
| Payables | $1.22B | $1.30B | $1.26B | $1.06B | $1.06B |
| -Accounts Payable | $1.22B | $1.30B | $1.26B | $1.06B | $1.06B |
| Short-Term Debt and Capital Lease Obligation | $15.02M | $14.92M | $14.75M | $19.24M | $19.24M |
| -Current Debt | $15.02M | $14.92M | $14.75M | $19.24M | $19.24M |
| Total Non-Current Liabilities | $51.33M | $51.46M | $51.18M | $68.07M | $68.07M |
| Long Term Debt and Capital Lease Obligation | $18.40M | $18.53M | $18.65M | $17.58M | $17.58M |
| -Long Term Debt | $15.51M | $15.38M | $15.28M | $15.75M | $15.75M |
| -Long Term Capital Lease Obligation | $2.89M | $3.15M | $3.38M | $1.83M | $1.83M |
| Other Non-Current Liabilities | $32.92M | $32.93M | $32.53M | $50.49M | $50.49M |
| Total Equity | $280.88M | $227.53M | $181.43M | $126.73M | $126.73M |
| Stockholders' Equity | $280.88M | $227.53M | $181.43M | $126.73M | $126.73M |
| Capital Stock | $168,000.00 | $168,000.00 | $166,000.00 | $4.15M | $4.15M |
| -Common Stock | $168,000.00 | $168,000.00 | $166,000.00 | $4.15M | $4.15M |
| Additional Paid-In Capital | $2.16B | $2.14B | $2.11B | $2.10B | $2.10B |
| Retained Earnings | -$1.88B | -$1.91B | -$1.93B | -$1.98B | -$1.98B |
| Gains/Losses Not Affecting Retained Earnings | -$143,000.00 | $154,000.00 | $479,000.00 | $916,000.00 | $916,000.00 |
| -Accumulated Depreciation | – | – | – | -$35.54M | -$35.54M |
| -Goodwill | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $49.87M | -$57.30M | $23.73M | -$105.76M | -$20.54M |
| Net cash flow from continuing operations | $49.87M | -$57.30M | $23.73M | -$105.76M | -$20.54M |
| Net Income from Continuing Operations | $34.91M | $17.96M | $48.92M | -$391.35M | -$188.88M |
| Gain/Loss from Continuing Operations | $979,000.00 | $7.60M | -$30.73M | -$12.17M | $33.05M |
| Depreciation & Depletion & Amortization | $6.74M | $6.86M | $6.79M | $28.59M | $6.97M |
| Other Non-Cash Items | $362,000.00 | $446,000.00 | $931,000.00 | -$5.52M | $53,000.00 |
| Change in Working Capital | -$11.98M | -$113.99M | -$8.43M | $189.47M | $82.67M |
| Net cash flow from investing | $17.82M | $19.91M | $19.27M | $88.61M | $22.58M |
| Net Cash Flow from Continuing Investing Activities | $17.82M | $19.91M | $19.27M | $88.61M | $22.58M |
| Net PPE Purchase and Sale | -$3.26M | -$3.45M | -$3.10M | -$13.24M | -$2.97M |
| Net Intangibles Purchase and Sale | $0.00 | -$860,000.00 | -$25,000.00 | -$29.87M | -$6.79M |
| Net Investment Purchase and Sale | $21.08M | $24.22M | $22.40M | $133.72M | $33.34M |
| Financing Cash Flow | -$124,000.00 | $4.63M | -$5.15M | -$2.99M | -$17,000.00 |
| Net Cash Flow from Continuing Financing Activities | -$124,000.00 | $4.63M | -$5.15M | -$2.99M | -$17,000.00 |
| Net Issuance Payments Of Debt | $0.00 | $0.00 | -$3.50M | $0.00 | $0.00 |
| Net Common Stock Issuance | -$124,000.00 | $4.63M | -$35,000.00 | -$2.99M | -$17,000.00 |
| Net Other Financing Charges | $0.00 | $0.00 | -$1.61M | – | – |
| Ending Cash Balance | $246.38M | $178.81M | $211.57M | $173.71M | $173.71M |
| Net Change in Cash | $67.57M | -$32.76M | $37.85M | -$20.15M | $2.03M |
| Beginning Cash Balance | $178.81M | $211.57M | $173.71M | $193.86M | $171.68M |
| Free Cash Flow | $46.62M | -$61.60M | $20.60M | -$148.87M | -$30.30M |
| -Change in Receivables | – | – | – | $344.59M | – |
| -Change in Prepaid Assets | – | – | – | -$65.44M | – |
| -Change in Payables and Accrued Expense | – | – | – | -$87.48M | – |
| -Change in Other Current Assets | – | – | – | -$133,000.00 | – |
| -Change in Other Current Liabilities | – | – | – | -$2.07M | – |
| Net Business Purchase and Sale | – | – | – | $0.00 | – |
| Net Other Investing Changes | – | – | – | -$2.00M | -$1.00M |
No comments yet — be the first to weigh in on AGL.
Sign in to join the discussion.